diabetics
Consumers Sue Zyprexa, Citing It Causes Diabetes
Filed in archive News by Rhys on August 31, 2006
Consumers Sue Zyprexa, Citing It Causes Diabetes
More and more people are taking legal action against the makers of Zyprexa, a well-known antipsychotic drug that many feel leads to diabetes.

Zyprexa is the brand name for olanzapine, an anti-psychotic drug used to treat schizophrenia and bipolar disorder. It was approved by the U.S. Food and Drug Administration in 1996. In 2004, Eli Lilly began including warning labels with Zyprexa regarding an increased risk of hyperglycemia and diabetes, especially in patients with a family history of diabetes.

"We believe the allegations linking Zyprexa and diabetes are not supported by scientific evidence," said Eli Lilly spokeswoman Terra Fox. She added that Zyprexa has not been approved for use in pediatric patients.

The warning information on http://www.fda.gov recommends regular glucose monitoring in patients who taking Zyprexa.

Fox added that the FDA has determined there is an increased risk for elevated blood glucose for people taking Zyprexa.

Fox would not comment about specific litigation.


You can read about the latest lawsuits here and here.

Permalink: Consumers Sue Zyprexa, Citing It Causes Diabetes
Tags: zyprexa  diabetes  causes  digital  citing  citing+causes  causes+diabetes  zyprexa+citing 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/36477
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Consumers Sue Zyprexa, Citing It Causes Diabetes:

  • Currently 6.75/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.75 out of 4 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!